"
Team:Paris Bettencourt/Policy
From 2014.igem.org
(Difference between revisions)
Zmarinkovic (Talk | contribs) |
Zmarinkovic (Talk | contribs) |
||
| Line 108: | Line 108: | ||
</div> | </div> | ||
<div id=descriptionmain> | <div id=descriptionmain> | ||
| - | <p> The policy part is a record of our research in | + | <p> The policy part is a record of our research in safety, bio policy and patenting law. In the process, we evaluated the biosafety issues in our project, wrote a consent form and collected information for patenting bacteria.</p> |
</div> | </div> | ||
</body> | </body> | ||
Latest revision as of 00:53, 18 October 2014
| SAFETY All the safety rules we followed in the lab, the training we received and the safety information about the bacteria we used. |
CONSENT FORM Why did we write a consent form? How did we go with it? And what is it like now? |
PATENTING Ever since patent law was established, it was constantly challenged and modified to suit the need of new industries. Nowadays, biotechnology is the new industry making patenting especially confusing. Here, we include our struggle with potential patenting related to our project. |
The policy part is a record of our research in safety, bio policy and patenting law. In the process, we evaluated the biosafety issues in our project, wrote a consent form and collected information for patenting bacteria.
Centre for Research and Interdisciplinarity (CRI)
Faculty of Medicine Cochin Port-Royal, South wing, 2nd floor
Paris Descartes University
24, rue du Faubourg Saint Jacques
75014 Paris, France
+33 1 44 41 25 22/25
paris-bettencourt-igem@googlegroups.com
+33 1 44 41 25 22/25
paris-bettencourt-igem@googlegroups.com 
